Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Epizyme, Inc. (EPZM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
11 Apr 2022
Kutok Jeffery
Chief Scientific Officer, Officer
Epizyme, Inc.
(EPZM)
94,563
-2%
2,741
$0.90
$2,466.90
SELL
7 Feb 2022
Agarwal Shefali
See Remarks, Officer
Epizyme, Inc.
(EPZM)
156,385
-0%
1,058
$1.50
$1,587.00
SELL
7 Feb 2022
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
28,632
-0%
222
$1.50
$333.00
SELL
2 Feb 2022
Kutok Jeffery
Chief Scientific Officer, Officer
Epizyme, Inc.
(EPZM)
97,304
-2%
2,556
$1.37
$3,501.72
SELL
2 Feb 2022
Agarwal Shefali
See Remarks, Officer
Epizyme, Inc.
(EPZM)
157,443
-1%
2,639
$1.37
$3,615.43
SELL
2 Feb 2022
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
28,854
-2%
687
$1.37
$941.19
BUY
31 Jan 2022
Legorreta Pablo G.
Director, 10% Owner
Epizyme, Inc.
(EPZM)
31,833,334
+247%
22,666,668
$1.50
$34,000,000.00
SELL
26 Jan 2022
Agarwal Shefali
See Remarks, Officer
Epizyme, Inc.
(EPZM)
160,082
-1%
2,922
$2.02
$5,902.44
SELL
6 Dec 2021
Agarwal Shefali
See Remarks, Officer
Epizyme, Inc.
(EPZM)
163,004
-1%
1,780
$2.93
$5,215.40
SELL
5 Apr 2021
Kutok Jeffery
Chief Scientific Officer, Officer
Epizyme, Inc.
(EPZM)
54,028
-3%
2,029
$8.80
$17,855.20
BUY
25 Mar 2021
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
150,683
+71%
62,717
$7.97
$500,099.90
SELL
25 Mar 2021
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
322,626
-3%
10,328
$7.85
$81,074.80
SELL
4 Feb 2021
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
104,341
-0%
969
$11.21
$10,862.49
SELL
4 Feb 2021
TOMBESI PAOLO
Chief Financial Officer, Officer
Epizyme, Inc.
(EPZM)
53,465
-1%
1,021
$11.21
$11,445.41
SELL
4 Feb 2021
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
83,188
-1%
894
$11.21
$10,021.74
SELL
4 Feb 2021
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
13,431
-1%
227
$11.21
$2,544.67
SELL
4 Feb 2021
Vakiener Victoria
Chief Commercial Officer, Officer
Epizyme, Inc.
(EPZM)
52,685
-1%
817
$11.21
$9,158.57
SELL
4 Feb 2021
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
331,977
-1%
3,890
$11.21
$43,606.90
SELL
25 Jan 2021
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
75,727
-3%
2,872
$11.41
$32,769.52
SELL
25 Jan 2021
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
55,957
-4%
2,872
$11.41
$32,769.52
SELL
25 Jan 2021
Vakiener Victoria
Chief Commercial Officer, Officer
Epizyme, Inc.
(EPZM)
27,982
-2%
599
$11.41
$6,834.59
SELL
25 Jan 2021
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
248,367
-2%
6,069
$11.41
$69,247.29
SELL
3 Dec 2020
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
76,089
-3%
2,522
$13.54
$34,147.88
BUY
11 Nov 2020
GOLDFISCHER CARL
Director
Epizyme, Inc.
(EPZM)
5,000
+100%
5,000
$12.07
$60,350.00
BUY
26 Jun 2020
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
82,601
+301%
62,019
$16.03
$994,164.60
SELL
25 Jun 2020
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
78,611
-2%
1,805
$16.15
$29,150.75
SELL
25 Jun 2020
TOMBESI PAOLO
Chief Financial Officer, Officer
Epizyme, Inc.
(EPZM)
21,942
-7%
1,805
$16.15
$29,150.75
SELL
25 Jun 2020
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
57,507
-4%
2,728
$16.15
$44,057.20
SELL
25 Jun 2020
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
4,838
-6%
317
$16.15
$5,119.55
SELL
25 Jun 2020
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
250,098
-1%
4,773
$16.15
$77,083.95
SELL
18 Jun 2020
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
51,798
-68%
112,003
$21.24
$2,378,443.50
SELL
18 Jun 2020
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
254,371
-7%
20,000
$22.00
$440,000.00
SELL
24 Mar 2020
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
71,991
-1%
1,243
$15.28
$18,993.04
SELL
24 Mar 2020
TOMBESI PAOLO
Chief Financial Officer, Officer
Epizyme, Inc.
(EPZM)
15,437
-7%
1,243
$15.28
$18,993.04
SELL
24 Mar 2020
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
51,798
-2%
1,243
$15.28
$18,993.04
SELL
24 Mar 2020
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
4,961
-4%
212
$15.28
$3,239.36
SELL
24 Mar 2020
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
254,371
-1%
3,285
$15.28
$50,194.80
SELL
3 Mar 2020
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
3,617
-21%
996
$22.18
$22,091.28
SELL
23 Jan 2020
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
58,803
-7%
4,473
$22.17
$99,168.72
SELL
23 Jan 2020
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
42,185
-4%
1,847
$24.64
$45,510.08
SELL
23 Jan 2020
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
1,042
-24%
330
$24.63
$8,127.90
SELL
23 Jan 2020
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
84,668
-9%
9,076
$21.82
$198,061.81
SELL
3 Sep 2019
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
5,958
-20%
1,514
$12.81
$19,393.51
SELL
27 Jun 2019
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
0
-100%
52,473
$12.43
$652,134.44
SELL
24 Jun 2019
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
52,473
-66%
104,944
$13.08
$1,372,825.00
SELL
14 Jun 2019
Agarwal Shefali
Chief Medical Officer, Officer
Epizyme, Inc.
(EPZM)
35,699
-3%
1,195
$11.97
$14,304.15
SELL
12 Jun 2019
Ros Matthew
See Remarks, Officer
Epizyme, Inc.
(EPZM)
39,032
-2%
1,185
$12.10
$14,338.50
SELL
12 Jun 2019
Beaulieu Joseph
Corporate Controller, Officer
Epizyme, Inc.
(EPZM)
497
-29%
203
$12.10
$2,456.30
SELL
12 Jun 2019
Bazemore Robert B
President & CEO, Director, Officer
Epizyme, Inc.
(EPZM)
84,994
-2%
2,074
$12.10
$25,095.40
BUY
5 Oct 2018
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
6,471,018
+6%
416,667
$9.00
$3,750,003.00
SELL
5 Feb 2018
Ros Matthew
Chief Operating Officer, Officer
Epizyme, Inc.
(EPZM)
3,122
-95%
72,264
$16.63
$1,201,694.50
SELL
24 Oct 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
8,123
-64%
15,000
$16.44
$246,591.00
SELL
25 Sep 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
8,123
-64%
15,000
$16.81
$252,076.50
BUY
18 Sep 2017
MOTT DAVID M
Director
Epizyme, Inc.
(EPZM)
6,054,351
+3%
200,000
$15.25
$3,050,000.00
SELL
24 Aug 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
7,228
-67%
15,000
$15.68
$235,266.00
SELL
24 Jul 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
7,228
-67%
15,000
$13.44
$201,571.50
SELL
30 Jun 2017
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
40,529
-6%
3,024
$15.50
$46,872.00
SELL
26 Jun 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
7,228
-67%
15,000
$14.87
$223,114.50
SELL
6 Jun 2017
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
31,538
-7%
2,500
$13.45
$33,625.00
SELL
25 May 2017
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
7,228
-67%
15,000
$16.11
$241,663.52
SELL
2 May 2017
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
31,538
-13%
5,000
$17.44
$87,212.49
SELL
4 Apr 2017
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
34,038
-12%
5,000
$16.36
$81,805.00
SELL
31 Mar 2017
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
36,175
-5%
2,013
$17.09
$34,394.12
SELL
9 Jan 2017
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
33,270
-2%
1,013
$12.04
$12,194.39
SELL
9 Dec 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
31,824
-3%
1,013
$11.03
$11,171.97
SELL
8 Dec 2016
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
5,520
-3%
200
$10.89
$2,178.82
SELL
9 Nov 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
30,378
-3%
1,013
$10.40
$10,535.20
SELL
10 Oct 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
28,931
-3%
1,013
$9.72
$9,848.18
SELL
9 Sep 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
27,485
-3%
1,013
$7.55
$7,651.19
SELL
9 Aug 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
26,039
-3%
1,013
$9.05
$9,165.52
SELL
1 Aug 2016
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
31,538
-11%
4,000
$10.37
$41,491.60
SELL
11 Jul 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
24,592
-3%
1,013
$10.36
$10,493.97
SELL
5 Jul 2016
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
0
-100%
4,000
$10.03
$40,127.60
SELL
9 Jun 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
23,146
-4%
1,013
$12.49
$12,655.51
SELL
9 May 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
22,096
-4%
1,013
$9.79
$9,914.27
SELL
11 Apr 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
20,253
-4%
1,013
$12.42
$12,583.42
SELL
11 Apr 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
20,253
-4%
1,013
$12.42
$12,583.42
SELL
9 Mar 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
18,907
-5%
1,006
$9.33
$9,386.40
BUY
29 Feb 2016
Ho Peter Tai-Ching
Chief Development Officer, Officer
Epizyme, Inc.
(EPZM)
5,358
+13%
636
$7.47
$4,751.87
SELL
8 Feb 2016
Singer Andrew E.
EVP & CFO, Officer
Epizyme, Inc.
(EPZM)
17,354
-41%
12,158
$9.54
$115,987.32
BUY
12 Jan 2016
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
BAY CITY CAPITAL LLC
10% Owner
Epizyme, Inc.
(EPZM)
3,370,562
+19%
555,555
$9.00
$4,999,995.00
BUY
12 Jan 2016
BARRIS PETER J
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
MOTT DAVID M
Director, 10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
KOLLURI KRISHNA KITTU
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
SANDELL SCOTT D
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
KERINS PATRICK J
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
Viswanathan Ravi
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
GOLDFISCHER CARL
Director
Epizyme, Inc.
(EPZM)
3,370,562
+19%
555,555
$9.00
$4,999,995.00
BUY
12 Jan 2016
BASKETT FOREST
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
BARRETT M JAMES
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
BUY
12 Jan 2016
Weller Harry R
10% Owner
Epizyme, Inc.
(EPZM)
5,854,351
+23%
1,111,111
$9.00
$9,999,999.00
SELL
4 Jan 2016
Copeland Robert A
President of Research and CSO, Officer
Epizyme, Inc.
(EPZM)
0
-100%
4,185
$15.58
$65,183.05
Home